The stock market indices followed through to the downside today, futures were down as well. The day started out down, with big drops at the opening, but they actually held the first five minutes, and then retested about thirty-forty minutes later successfully. That resulted in a big rally, the Nasdaq 100 going from 4643, all the way up to 4703, a 60-point run up, and the S&P 500 going from 2052 to 2074. That was a very big move for the indices. They then pulled back and consolidated, which you would expect. An afternoon high on the Nasdaq 100 was not confirmed by the S&P 500 as the S&P 500 failed to get through its 3-day declining topsline three times in the afternoon. They bounced after retesting support, and backed off the last five minutes to close mixed on the day.

Net on the day, the Dow was down 162.51 at 17,568.00. The S&P 500 was down 13.48 to 2063.59, 11 points off its low, but still a nasty decline. The Nasdaq 100 managed to close up 1.15 to 4694.66, 51 points off its low.

Advance-declines were 2 to 1 negative on New York Stock Exchange and 3 to 2 negative on Nasdaq. Up/down volume was almost 3 to 1 negative on New York with total volume of over 4 billion shares. Nasdaq traded 1.8 billion and had a nearly 4 to 3 negative volume ratio.

TheTechTrader.com board had a mixed picture today. Priceline.com (PCLN) jumped 1.55 to 1303.97, Amazon.com Inc. (AMZN) popped 7.50 to 677.33, and Netflix, Inc. (NFLX) managed to come 5 points off its low, and run up 1.62 to 126.98, but Google Inc. (GOOG) dropped 88 cents to 762.37, and Apple Inc. (AAPL) fell just a nickel to 118.23.

Tesla Motors, Inc. (TSLA) gave back 4.41 to 226.72. Baidu, Inc. (BIDU) lost 3.52 to 205.02.

Weight Watchers International, Inc. (WTW) was down 1.33 to 24.84, pulling back on profit taking.

Some of the biotech's were strong today. Prothena Corporation plc (PRTA) was up 4.70 to 68.25, NewLink Genetics Corporation (NLNK) up 1.66 to 34.65, Intra-Cellular Therapies, Inc. (ITCI) 2.75 to 54.77.

The Direxion Daily S&P Biotech Bull 3X ETF (LABU) gained 1.15 to 20.36, which dropped as low as 18.30 this morning.

FireEye, Inc. (FEYE) jumped 1.35 to 21.54 on an upgrade.

Checking the TheTechTrader.com percent-gain leaderboard, Pieris Pharmaceuticals, Inc. (PIRS), on positive drug news, gained 73 cents to 2.79, or 35%, on 6 million shares. Acorn International, Inc. (ATV) bounced 30 cents to 9.54, or 17%, having reached 10.56 today. Century Casinos Inc. (CNTY) worked its way up 67 cents to 7.38, or 10%.

TherapeuticsMD, Inc. (TXMD) exploded 2.53 to 9.06, or 39%, on 25 million shares, reaching as high as 9.81 earlier in the day. Oramed Pharmaceuticals Inc. (ORMP) bounced 1.04 to 9.44, or 12%.

Galapagos NV (GLPG) advanced 6.97 to 54.93, or 15%. The Children's Place, Inc. (PLCE) ran 6.12 to 54.88, or 13%, on 2.2 million shares. Central Garden & Pet Company (CENT), which we traded today, stair-stepped its way up 1.92 to 16.98, or 13%. Cara Therapeutics Inc. (CARA) closed up 1.40 to 15.18, or 10%.

Eagle Pharmaceuticals Inc. (EGRX), which we traded today, popped and ran all day, up 18.29 to 100.21, or 22%, on 1.2 million shares.

Stepping back and reviewing the hourly chart patterns, the indices had a big dip at the opening to key support, double-bottomed, rallied sharply, pulled back midday to consolidate, made new highs on the Nasdaq 100, but the S&P 500 couldn't confirm, and they backed off into the close to close lower on the blue chips, and flat on the Nasdaq 100.

Let's see how it goes tomorrow.

Good Trading!

In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.

Recommended Content


Recommended Content

Editors’ Picks

EUR/USD holds gains above 1.0700, as key US data loom

EUR/USD holds gains above 1.0700, as key US data loom

EUR/USD holds gains above 1.0700 in the European session on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data. 

EUR/USD News

GBP/USD extends recovery above 1.2500, awaits US GDP data

GBP/USD extends recovery above 1.2500, awaits US GDP data

GBP/USD is catching a fresh bid wave, rising above 1.2500 in European trading on Thursday. The US Dollar resumes its corrective downside, as traders resort to repositioning ahead of the high-impact US advance GDP data for the first quarter. 

GBP/USD News

Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP

Gold price edges higher amid weaker USD and softer risk tone, focus remains on US GDP

Gold price (XAU/USD) attracts some dip-buying in the vicinity of the $2,300 mark on Thursday and for now, seems to have snapped a three-day losing streak, though the upside potential seems limited. 

Gold News

XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger

XRP extends its decline, crypto experts comment on Ripple stablecoin and benefits for XRP Ledger

Ripple extends decline to $0.52 on Thursday, wipes out weekly gains. Crypto expert asks Ripple CTO how the stablecoin will benefit the XRP Ledger and native token XRP. 

Read more

US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4

US Q1 GDP Preview: Economic growth set to remain firm in, albeit easing from Q4

The United States Gross Domestic Product (GDP) is seen expanding at an annualized rate of 2.5% in Q1. The current resilience of the US economy bolsters the case for a soft landing. 

Read more

Majors

Cryptocurrencies

Signatures